GR3025135T3 - Selective adenosine receptor agents - Google Patents
Selective adenosine receptor agentsInfo
- Publication number
- GR3025135T3 GR3025135T3 GR970402767T GR970402767T GR3025135T3 GR 3025135 T3 GR3025135 T3 GR 3025135T3 GR 970402767 T GR970402767 T GR 970402767T GR 970402767 T GR970402767 T GR 970402767T GR 3025135 T3 GR3025135 T3 GR 3025135T3
- Authority
- GR
- Greece
- Prior art keywords
- adenosine receptor
- selective adenosine
- receptor agents
- agents
- selective
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/499,111 US5047534A (en) | 1990-03-26 | 1990-03-26 | Selective adenosine receptor agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GR3025135T3 true GR3025135T3 (en) | 1998-02-27 |
Family
ID=23983864
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GR970402767T GR3025135T3 (en) | 1990-03-26 | 1997-10-22 | Selective adenosine receptor agents |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US5047534A (el) |
| EP (1) | EP0449175B1 (el) |
| JP (1) | JP3181305B2 (el) |
| KR (1) | KR100195368B1 (el) |
| CN (1) | CN1032815C (el) |
| AR (1) | AR247887A1 (el) |
| AT (1) | ATE156130T1 (el) |
| AU (1) | AU632914B2 (el) |
| CA (1) | CA2038747C (el) |
| DE (1) | DE69127010T2 (el) |
| DK (1) | DK0449175T3 (el) |
| ES (1) | ES2107431T3 (el) |
| FI (1) | FI98461C (el) |
| GR (1) | GR3025135T3 (el) |
| HU (1) | HU208824B (el) |
| IE (1) | IE910982A1 (el) |
| IL (1) | IL97656A (el) |
| NO (1) | NO177591C (el) |
| NZ (1) | NZ237484A (el) |
| PH (1) | PH27511A (el) |
| PT (1) | PT97133B (el) |
| ZA (1) | ZA912038B (el) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5208240A (en) * | 1991-03-12 | 1993-05-04 | Merrell Dow Pharmaceuticals Inc. | 8-substituted purines as selective adenosine receptor agents |
| CA2116967C (en) * | 1992-07-08 | 2003-08-19 | Fumio Suzuki | Antidepressants |
| WO1994019349A1 (en) * | 1993-02-26 | 1994-09-01 | Merrell Dow Pharmaceuticals Inc. | Xanthine derivatives as adenosine a1 receptor antagonists |
| WO1994025462A1 (en) * | 1993-05-03 | 1994-11-10 | The United States Of America, Represented By The | 8-substituted 1,3,7-trialkyl-xanthine derivatives as a2-selective adenosine receptor antagonists |
| NZ265790A (en) * | 1993-05-06 | 1996-10-28 | Merrell Dow Pharma | 8-tetrahydronaphthyl or 2-phenyl-pentyl or -hexyl substituted xanthine derivatives and pharmaceutical compositions |
| US5629298A (en) * | 1995-03-13 | 1997-05-13 | University Of Massachusetts Medical Center | Adenosine as a positive inotrop in the compromised heart |
| GB9819382D0 (en) | 1998-09-04 | 1998-10-28 | Cerebrus Ltd | Chemical compounds I |
| US6258794B1 (en) | 1999-12-14 | 2001-07-10 | The Mclean Hospital Corporation | Treatment of mental conditions including depression |
| DE602004029160D1 (el) | 2003-06-10 | 2010-10-28 | Kyowa Hakko Kirin Co Ltd | |
| WO2007036491A1 (de) * | 2005-09-30 | 2007-04-05 | Basf Aktiengesellschaft | Verfahren zur herstellung von alpha-substituierten carbonsäuren |
| US7592461B2 (en) * | 2005-12-21 | 2009-09-22 | Bristol-Myers Squibb Company | Indane modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof |
| KR102060903B1 (ko) * | 2018-09-12 | 2019-12-30 | 김지훈 | 다중접합 도마 및 그 제조방법 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1435916A (en) * | 1972-05-11 | 1976-05-19 | Beecham Group Ltd | Pharmaceutical weight-reducing compositions |
| SE416810C (sv) * | 1977-10-14 | 1982-05-11 | Draco Ab | Forfarande for framstellning av xantinderivat med antiallergisk aktivitet |
| JPS57198544A (en) * | 1981-05-28 | 1982-12-06 | Sony Corp | Manufacture of magnetic recording medium |
| US4593095A (en) * | 1983-02-18 | 1986-06-03 | The Johns Hopkins University | Xanthine derivatives |
| US4772607A (en) * | 1986-05-20 | 1988-09-20 | Warner-Lambert Company | Dialkenyl derivatives of xanthine, pharmaceutical compositions and methods of use therefor |
| US4783530A (en) * | 1986-11-13 | 1988-11-08 | Marion Laboratories, Inc. | 8-arylxanthines |
| DE3843117A1 (de) * | 1988-12-22 | 1990-06-28 | Boehringer Ingelheim Kg | Neue xanthinderivate mit adenosin-antagonistischer wirkung |
-
1990
- 1990-03-26 US US07/499,111 patent/US5047534A/en not_active Expired - Fee Related
-
1991
- 1991-03-19 ZA ZA912038A patent/ZA912038B/xx unknown
- 1991-03-19 NZ NZ237484A patent/NZ237484A/xx unknown
- 1991-03-19 AU AU73537/91A patent/AU632914B2/en not_active Ceased
- 1991-03-20 AR AR91319262A patent/AR247887A1/es active
- 1991-03-21 CA CA002038747A patent/CA2038747C/en not_active Expired - Fee Related
- 1991-03-22 IL IL9765691A patent/IL97656A/en not_active IP Right Cessation
- 1991-03-22 PH PH42193A patent/PH27511A/en unknown
- 1991-03-25 NO NO911200A patent/NO177591C/no not_active IP Right Cessation
- 1991-03-25 EP EP91104668A patent/EP0449175B1/en not_active Expired - Lifetime
- 1991-03-25 KR KR1019910004660A patent/KR100195368B1/ko not_active IP Right Cessation
- 1991-03-25 IE IE098291A patent/IE910982A1/en not_active IP Right Cessation
- 1991-03-25 FI FI911420A patent/FI98461C/fi active
- 1991-03-25 ES ES91104668T patent/ES2107431T3/es not_active Expired - Lifetime
- 1991-03-25 HU HU91985A patent/HU208824B/hu not_active IP Right Cessation
- 1991-03-25 DE DE69127010T patent/DE69127010T2/de not_active Expired - Fee Related
- 1991-03-25 AT AT91104668T patent/ATE156130T1/de not_active IP Right Cessation
- 1991-03-25 PT PT97133A patent/PT97133B/pt not_active IP Right Cessation
- 1991-03-25 CN CN91101892A patent/CN1032815C/zh not_active Expired - Fee Related
- 1991-03-25 DK DK91104668.8T patent/DK0449175T3/da active
- 1991-03-26 JP JP08451291A patent/JP3181305B2/ja not_active Expired - Fee Related
-
1997
- 1997-10-22 GR GR970402767T patent/GR3025135T3/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HU9300964D0 (en) | Nucleoside derivatives | |
| ZA89440B (en) | Dideoxydidehydrocarbocyclic nucleosides | |
| HU913074D0 (en) | Fibrinogenic receptor antagonists | |
| OA09677A (en) | Nucleoside derivatives | |
| GB2217320B (en) | Dideoxydidehydrocarbocyclic nucleosides | |
| GB2264948B (en) | Human adenosine receptors | |
| ZA913721B (en) | Antiviral agents | |
| IL97486A0 (en) | Neurospora expression system | |
| EP0449175A3 (en) | Selective adenosine receptor agents | |
| EP0497988A4 (en) | Antiviral agent | |
| GB9014194D0 (en) | Antiparasitic agents | |
| ZA902282B (en) | Selective adenosine receptor compounds | |
| GB9008202D0 (en) | Cushion | |
| IL106287A0 (en) | Receptor derivatives | |
| FI955257A (fi) | 8-substituoidut-ksantiinit valikoivina adenosiinireseptoriaineina | |
| EP0450102A4 (en) | Nucleoside derivative | |
| ZA934873B (en) | Receptor derivatives | |
| ZA911154B (en) | Therapeutic nucleosides | |
| GB9110987D0 (en) | Dideoxydidehydrocarboxyclic nucleosides | |
| EP0539587A4 (en) | Antiretroviral agent | |
| GB9017922D0 (en) | Antiparasitic agents | |
| GB9007566D0 (en) | Nucleoside derivatives | |
| GB9007650D0 (en) | Nucleoside derivatives | |
| GB9007651D0 (en) | Nucleoside derivatives | |
| IE892332L (en) | Nucleosides |